Bacteria naturally present in the human intestine can transform cholesterol-derived bile acids into powerful metabolites that strengthen anticancer immunity by blocking androgen signaling, according to a preclinical study.
A person’s “bioenergetic age” – or how youthfully their cells generate energy – might be a key indicator of whether they’re at risk of developing Alzheimer’s disease, new research from Weill Cornell Medicine shows.
Weill Cornell Medicine physician-scientists Dr. Niroshana Anandasabapathy and Dr. Rohit Chandwani have been elected members of the American Society for Clinical Investigation for 2025.
Researchers at Weill Cornell Medicine developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy.
Three new research projects will receive funding and training through the Ignite Fellow for New Ventures program to transform university research into new ventures and products that can benefit society.
A study out of Weill Cornell Medicine and Oregon Health & Science University provides critical insight for the development of a vaccine that can more effectively block the spread of cytomegalovirus across the placenta to babies before they're born.
A total of 450 expected graduates in the Class of 2025 received their degrees from Weill Cornell Medicine during the institution’s annual Commencement ceremony, held May 15 at Carnegie Hall.